Samjin Pharmaceutical Co., Ltd.
About Samjin Pharmaceutical Co., Ltd.
Certifications
Categories
-
Country/Region:Korea, Republic Of
-
On CPHI since:2022
-
Certificates:2
-
Employees:500 - 999
Company types
Primary activities
Products from Samjin Pharmaceutical Co., Ltd. (3)
-
Product Clopidogrel Tablet
Indication: Antiplatelet API: Clopidogrel Bisulfate 75mg BE data: Available CTD: Available Export: Philippines, Singapore. -
Product Ironject Injection
Active Ingredient: Ferric Carboxymaltose 10mL, 2mL Indication: Iron Deficiency Anemia (IDA) -
Product Letrozole Tablet
Oncology Indication: Postmenopausal hormone receptor-positive breast cancer API: Letrozole 2.5mg BE data: Available CTD: Available
Samjin Pharmaceutical Co., Ltd. Resources (1)
-
Brochure Brochure for CPhI Milan 2026
Company profile & Product list


